Herpes simplex virus 1 UL41 protein abrogates the antiviral activity of hZAP by degrading its mRNA by unknown
RESEARCH Open Access
Herpes simplex virus 1 UL41 protein
abrogates the antiviral activity of hZAP by
degrading its mRNA
Chenhe Su1, Jie Zhang2 and Chunfu Zheng1,3*
Abstract
Background: The zinc finger antiviral protein (ZAP) is a host restriction factor that inhibits the replication of various
viruses by degradation of certain viral mRNA. However, previous study demonstrated that ectopic expression of rat
ZAP did not suppress the replication of herpes simplex virus type 1 (HSV-1), an archetypal member of the
alphaherpesvirus subfamily, and the molecular mechanism underneath is still illusive.
Results: Human ZAP (hZAP) does not suppress the replication of herpes simplex virus 1, and HSV-1 UL41 protein
was identified as an antagonist of hZAP by degrading its mRNA. Infection of wild-type (WT), but not UL41-null
mutant (R2621) virus, diminished the accumulation of hZAP to abrogate its antiviral activity. Moreover, ectopic
expression of hZAP inhibited the replication of R2621 but not WT HSV-1.
Conclusion: HSV-1 UL41 was shown for the first time to evade the antiviral function of hZAP via its RNase activity.
Keywords: HSV-1, hZAP, UL41, Immune evasion
Background
Herpes simplex virus 1 (HSV-1) is the archetypal member
of the alphaherpesvirus subfamily with a large genome en-
coding over 80 viral proteins. UL41 is a HSV-1 tegument
protein, and also a minor structural component of HSV-1
virions [1, 2], and it can degrade host mRNAs by cutting
them at preferred site [3–5]. Upon HSV-1 infection, UL41
polypeptides enter the cell as components of infecting
virions and contributes to an overall decrease in host pro-
tein synthesis [6]. By shortening the half-life of mRNAs,
UL41 helps to redirect the cell from host to viral gene
expression, and facilitates the sequential expression of dif-
ferent classes of viral genes [7]. Therefore, HSV-1 evades
host responses to infection and diverts the resources of
the cells to viral macromolecular synthesis.
The ZAP (zinc finger antiviral protein) was originally
discovered in rat as an antiretroviral factor [8]. The viruses
that contain ZAP-responsive element (ZRE) in their viral
mRNAs are sensitive to ZAP [9]. Human ZAP (hZAP) ex-
ists in two isoforms, hZAPL and hZAPS respectively [10].
Both hZAP isoforms have antiviral effects against several
RNA viruses [11, 12], while only ZAPS, not ZAPL was
up-regulated under IFN treatment [13, 14].
HSV-1 UL41 is an endoribonuclease with the substrate
specificity of RNase A [15]. ZAP could not inhibit HSV-1
infection [16], and the molecular mechanism underneath
is still illusive. In this study, we show for the first time that
HSV-1 UL41 abrogate s hZAP’s antiviral activity by
degrading hZAP mRNA.
Results
HSV-1 UL41 protein antagonized the antiviral activity of
hZAP
Previous study showed that ectopic expression of rat
ZAP did not affect HSV-1 infection [16]. To investigate
whether hZAP could inhibit HSV-1 infection,
293TRex-hZAPL/ZAPS cells, which expressed ZAPL/
ZAPS in a tetracycline (Tet)-inducible manner, were
infected with HSV-1-BAC-Luc at an MOI of 0.1, 1 or
10 and then mock-treated or treated with 100 ng/mL
or 1000 ng/mL Tet [12, 17]. Luciferase activity was
measured to determine the replication of viruses. As a
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result, different MOI of HSV-1 replicated similarly
in mock and hZAPL- or hZAPS-expressing cells
(Fig. 1a, b and data not shown). Viral plaque assay
was also conducted and similar result was obtained
(data not shown). These results demonstrate that
hZAP does not inhibit HSV-1 infection.
To determine whether any of HSV-1 proteins could
dampen the antiviral activity of hZAP, a high-throughput
screening assay was applied to test all HSV-1 encoded
proteins [18]. Tetracycline treatment resulted in strong in-
hibition of NL4-3-luc expression, which contains the most
of the sequence of the HIV-1 genome [12]. In contrast,
ectopic expression of UL41 significantly promoted the ex-
pression of NL4-3-luc under tetracycline treatment, but
not the other proteins of HSV-1 (Fig. 1c). Ectopic expres-
sion of UL41 could also facilitate VSV-G-pseudotyped
NL4-3-luc virus infection in 293Trex-hZAPL cells or
293Trex-hZAPS cells in a dose dependent manner (data
not shown). Taken together, these results demonstrate that
UL41 antagonizes the antiviral activity of hZAP.
HSV-1 UL41 protein downregulated the expression of
hZAP
The aforementioned results demonstrated that UL41
was an antagonist of hZAP protein. In order to clarify
the molecular mechanism of UL41 to abrogate hZAP
antiviral activity, HEK 293 T cells were co-transfected
with hZAPS-Myc plasmid and increasing amounts of
UL41-Flag plasmids. As a result, ectopic expression of
UL41-Flag reduced the abundance of hZAPS in a dose
dependent manner (Fig. 2a).
Fig. 1 HSV-1 UL41 protein abrogated the antiviral activity of hZAP. a and b 293Trex-hZAPL cells and 293Trex-hZAPS cells were infected with
HSV-1-BAC-Luc at an MOI of 1. Cells were treated or mock treated with tetracycline (100 ng/mL or 1000 ng/mL) 2 h post-infection to induce
hZAP expression. The cells were lysed, and luciferase activities were measured at 36 h after infection. Fold inhibition was calculated as the ratio
of the luciferase activity in mock-treated cells to that in tetracycline-treated cells. c 293Trex-hZAPS cells were transfected with 500 ng of
NL4-3-Luc reporter plasmid, together with Renilla luciferase plasmid pRL-TK (50 ng) and pEYFP-N1 control vector or plasmids encoding the
indicated viral proteins (1000 ng). At 6 h post-transfection, cells were treated with or without tetracycline (1000 ng/mL) to induce hZAPS
expression and were incubated for additional 36 h, followed by cell lysis. The luciferase activity was determined by a dual-luciferase assay.
Data shown are means ± SD from three separate experiments. (*P < 0.05)
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To investigate whether hZAP was downregulated during
HSV-1 infection, 293Trex-hZAPL cells or 293Trex-hZAPs
cells were infected with WT HSV-1 or R2621 at an MOI of
0.1, 1 and 10. As a result, hZAPL and hZAPS were signifi-
cantly decreased during WT HSV-1 infection at an MOI of
10, while R2621 did not affect the expression of hZAPL
and hZAPS (Fig. 2b, c). Taken together, all these results
suggest that UL41 reduced the expression of hZAP.
HSV-1 UL41 protein promoted the degradation of hZAP
mRNA
UL41 was an endoribonuclease with its substrate specifi-
city similar to that of RNase A [15]. Therefore, we
hypothesize that UL41 decreases hZAP expression via
its RNase activity to degrade hZAP mRNA. To test this
hypothesis, UL41-Flag plasmid was transfected into
293Trex-hZAPL and 293Trex-hZAPS cells, and cells were
treated with tetracycline (1000 ng/mL) 6 h post-
transfection. As a result, ectopic expression of UL41-Flag
downregulated the abundance hZAPL and hZAPS mRNA
in a dose dependent manner (Fig. 3a).
To investigate whether the mRNA of hZAP was down-
regulated during viral infection, 293Trex-hZAPL and
293Trex-hZAPs cells were infected with WT HSV-1 or
R2621 at an MOI of 1 and 10. As a result, the mRNA
levels of hZAPL and hZAPS were significantly decreased
during WT HSV-1 infection at an MOI of 10 (Fig. 3b).
However, R2621 failed to degrade hZAPL and hZAPS
mRNA (Fig. 3b), indicating that UL41 was responsible for
the degradation of hZAPL and hZAPS mRNA. Taken to-
gether, these results demonstrated that UL41 dampened
the antiviral activity of hZAP by degradation its mRNA.
Ectopic expression of hZAP inhibited UL41-null mutant
HSV-1 infection
Our previous results suggested that HSV-1 UL41 protein
reduced the antiviral activity of hZAP by degradating its
mRNA. However, the UL41-null virus R2621 exerts no
such function, which leads us to wonder whether hZAP
could inhibit R2621 infection. Thus, 293Trex-hZAPL
cells or 293Trex-hZAPS cells were infected with WT
HSV-1 or R2621 at an MOI of 1. At 2 h post-infection,
the cells were treated or mock treated with tetracycline
(1000 ng/mL). Western blot (WB) was performed to
analyze the replication of these viruses 36 h post infec-
tion. As a result, the expression levels of ICP0 and UL46
in WT HSV-1 infected hZAPS and hZAPL-expression
cells were similar to the WT HSV-1 infected mock
treated cells. While the expression levels of ICP0 and
UL46 in R2621 infected cells were inhibited by hZAPS
or hZAPL expression compared to the R2621 infected
mock treated cells (Fig. 4a, b). WT HSV-1 or R2621 viral
growth curves were also examined through viral plague
assays. As a result, ectopic expression of hZAPL or
hZAPS inhibited UL41-null HSV-1 replication, but not
WT HSV-1 replication (Fig. 4c-f). Taken together, these
results indicate UL41 promotes HSV-1 infection by an-
tagonizing the antiviral activity of hZAP.
Discussion
ZAP is an intrinsic host antiviral factor, which has been
reported to not only inhibit the infection of a variety of
RNA viruses [8, 11, 12, 16, 19], but also several DNA
Fig. 2 HSV-1 UL41 protein inhibits the expression of hZAP. a HEK
293 T cells were co-transfected with hZAPS-Myc plasmid along with
increasing amounts of UL41-Flag plasmid. 24 h after transfection, cells
were lysed and the samples were then subjected to WB analysis. The
lower panel presented relative density analysis of hZAPS. b and c
293Trex-hZAPL cells and 293Trex-hZAPS cells were infected with WT
HSV-1 or R2621 at an MOI of 0.1, 1 or 10, respectively. At 2 h
post-infection, cells were mock treated or treated with tetracycline
(1000 ng/mL). Cells were lysed and the samples were subjected to WB
analysis 36 h post-infection. The relative density analysis of hZAPL and
hZAPS were under the WB results, respectively. One representative of
three independent experiments was shown
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viruses [9, 14]. ZAP specifically inhibits the replication
of many viruses by preventing the accumulation of viral
mRNAs in the cytoplasm [20]. However, previous study
showed that HSV-1 could resist the antiviral effect of
ZAP [16]. In this study, we showed that hZAP does not
suppress HSV-1 replication using the recombinant HSV-
1 BAC-Luc, which behaved indistinguishably from the
wild-type HSV-1 but could be easily quantified in vitro
due to its luciferase activity [17]. Furthermore, HSV-1
UL41 protein was demonstrated for the first time to
degrade hZAP mRNA and dampen the antiviral activity
of hZAP.
UL41 triggers degradation of host mRNAs and rapid
shutoff of host cell protein synthesis [21]. By shortening
the half-life of mRNAs, UL41 helps redirect the cell
from host to viral gene expression, and facilitates the se-
quential expression of different classes of viral genes [7].
And three amino acid residues E192, D194, and D195 of
UL41 are essential for the nuclease activity [15]. UL41
mutants reportedly display a 5- to 10-fold reduction in
virus yield in tissue culture infection [1, 7, 22]. Previous
studies demonstrated that UL41 could inhibit IFN-
mediated antiviral response via multiple mechanisms [23].
Moreover, UL41 was reported to reduce the expression of
innate immune sensors, such as TLR2, TLR3, RIG-I and
Mda-5 [24]. and block IFN-γ signaling by reducing the ex-
pression of the IFN-gamma receptor alpha chain (IFNGR1)
[25]. Here, we found that UL41 could degrade hZAP
mRNA, and that may facilitate the replication of HSV-1.
ZAP is an interferon-inducible gene and exhibits intrinsic
antiviral activity [26, 27]. Previous study demonstrated that
MHV-68 infection up-regulates ZAP expression. ZAP in-
hibits the expression of MHV-68 ORF64, but MHV-68
RTA antagonizes the antiviral activity of ZAP [28]. In this
study, we demonstrate that HSV-1 infection down-
regulates hZAP expression, and HSV-1 UL41 degrades
hZAP mRNA. These findings will lead to a better under-
standing of the mechanisms employed by HSV-1 UL41 to
dampen host antiviral signaling and develop the therapeutic
interventions to modulate HSV-1 pathogenesis.
Conclusions
In summary, we have shown here for the first time that
HSV-1 UL41 abrogate s the antiviral activity of hZAP by
targeting its mRNA for degradation, and consequently
inhibiting the expression of hZAP. These findings will
lead to a better understanding of the mechanisms
employed by HSV-1 UL41 to dampen host antiviral
signaling and develop the therapeutic interventions to
modulate HSV-1 pathogenesis.
Materials and methods
Cells, viruses and antibodies
HEK 293 T cells, Vero cells, 293Trex-hZAPL and
293Trex-hZAPS cells were cultured in Dulbecco’s modi-
fied Eagle medium (DMEM) (Gibco-BRL) supplemented
with 10 % fetal bovine serum (FBS) and 100 U/ml of
penicillin and streptomycin. WT HSV-1 (strain F) and
Fig. 3 HSV-1 UL41 protein promotes hZAP mRNA degradation. a 293Trex-hZAPL or 293Trex-hZAPS cells were transfected with pCMV-Flag control
vector or increasing amount of UL41-Flag plasmid. At 6 h post-transfection, cells were mock treated or treated with tetracycline (1000 ng/mL) to
induce hZAPL or hZAPS expression. Quantitative RT-PCR analysis was then performed to detect the mRNA level of hZAPL or hZAPS. b 293Trex-hZAPL
cells or 293Trex-hZAPS cells were infected with WT HSV-1 or R2621 at an MOI of 1 or 10, respectively. At 2 h post-infection, cells were mock treated or
treated with tetracycline (1000 ng/mL). Quantitative RT-PCR analysis was then performed to detect the mRNA level of hZAPL or hZAPS. One
representative of three independent experiments was shown. (*P < 0.05, **P < 0.01)
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HSV-1-BAC-Luc (expressing firefly luciferase) were
multiplied, titered and purified as previously described
[17]. The UL41-null mutant virus (R2621) was propa-
gated and titered as described previously [29].
Mouse anti-Myc and anti-Flag monoclonal antibodies
(MAbs), Rabbit polyclonal anti-ZAPL and Rabbit poly-
clonal anti-ZAPS, Mouse anti-β-actin MAb were purchased
from ABmart (Shanghai, China), Proteintech (Wuhan,
China), Santa Cruz Biotechnology (Santa Cruz, CA),
respectively. Rabbit polyclonal anti-ICP0, UL42 and UL46
were purchased from GL Biochem Ltd. (Shanghai, China),
and Rabbit polyclonal anti-UL41 was kindly provided
by Dr. Roizman. Tetracycline (Tet) was purchased
from Biovision (San Francisco, CA).
Transfection, infection and dual-luciferase reporter (DLR)
assay
HEK 293 T cells were transfected by standard calcium
phosphate precipitation whereas hZAP-expressing cells
were transfected using Lipofectamine 2000 (Invitrogen).
VSV-G-pseudotyped NL4-3-luc virus were produced by
transiently co-transfecting HEK 293 T cells with pVSV-G
plasmid and pNL4-3-luc. 293Trex-hZAPS cells were co-
transfected with reporter plasmid pNL4-3-Luc and
internal control plasmid pRL-TK, with or without expres-
sion plasmids. At 6 h post-transfection, cells were mock
treated or treated with Tetracycline (1000 ng/mL) for
36 h, and then luciferase assays were performed as previ-
ously described [30].
Fig. 4 Expression of hZAP inhibits UL41-null mutant HSV-1 R2621 infection. a and b 293Trex-hZAPL cells or 293Trex-hZAPS cells were infected
with WT HSV-1 or R2621 at an MOI of 1, respectively. At 2 h post-infection, cells were mock treated or treated with tetracycline (1000 ng/mL). At
36 h post-infection, cells were lysed and subjected to WB analysis with the indicated Ab. c and d 293Trex-hZAPL cells or 293Trex-hZAPS cells were
infected with WT HSV-1. After 2 h post-infection, cells were treated with or without Tet (1000 ng/mL) to induce hZAPL or hZAPS expression. Viral growth
curves were generated by traditional plaque assays at the indicated time points. e and f 293Trex-hZAPL cells or 293Trex-hZAPS cells were infected with
R2621 virus. After 2 h post-infection, cells were treated with or without Tet (1000 ng/mL) to induce hZAPL or hZAPS expression. Viral growth curves were
generated by traditional plaque assays at the indicated time points. One representative of three independent experiments was shown. (*P< 0.05)
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RNA isolation, quantitative RT-PCR
Total RNA was extracted using Trizol (Invitrogen,
California) according to the manufacturer’s manual.
Samples were digested with DNase I and subjected to
reverse transcription previously described [30]. The
cDNA was used as template for quantitative PCR
(qPCR) to investigate the expression of hZAP. qPCR
was performed according to the manufacturer’s in-
structions (SYBR Premix Ex Taq, Takara, Japan), and
18S rRNA was used as internal reference.
Statistical Analysis
The data were evaluated with the Student’s t-test and
p < 0.05 were considered statistically significant.
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